Literature DB >> 23942723

[HPV in urology. Basic principles and controversies].

P Schneede1, R Waidelich.   

Abstract

The information presented in this article summarizes some of the basic knowledge on human papillomavirus (HPV) infections and the consequences particularly in men. According to current understanding most HPV infections are latent and transient in immunocompetent patients but some will persist. Predominantly due to the different oncogenic potential of various HPV types, persisting infections can give rise to benign or malignant neoplasms in both genders. Current controversies, such as the need for HPV testing in men or routine male HPV vaccination will be discussed. High-risk male populations, e.g. men who have sex with men (MSM) and HIV positive men, merit special attention from urologists in the future. The groups of HIV positive MSMs are at an extremely high risk of developing anal cancer that currently even exceeds the highest reported incidence of cervical cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23942723     DOI: 10.1007/s00120-013-3257-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  23 in total

1.  [Urethral condyloma in a patient with neurogenic bladder dysfunction: a therapeutic challenge].

Authors:  P Bartel; K Göcking; J Pannek
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

Review 2.  Prevalence of HPV infection among men: A systematic review of the literature.

Authors:  Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

Review 3.  Human papillomavirus testing in men.

Authors:  Kathleen F McGinley; Wayne Hey; David O Sussman; Gordon A Brown
Journal:  J Am Osteopath Assoc       Date:  2011-03

Review 4.  Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

Authors:  Lucija Tomljenovic; Jean Pierre Spinosa; Christopher A Shaw
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.

Authors:  Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

Review 6.  Screening for human papillomavirus: is urine useful?

Authors:  K W D'Hauwers; W A Tjalma
Journal:  Indian J Cancer       Date:  2009 Jul-Sep       Impact factor: 1.224

Review 7.  Human papillomavirus-related disease in people with HIV.

Authors:  Joel Palefsky
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

Review 8.  Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.

Authors:  D Pathirana; P Hillemanns; K-U Petry; N Becker; N H Brockmeyer; R Erdmann; L Gissmann; H Grundhewer; H Ikenberg; A M Kaufmann; J Klusmann; I Kopp; H Pfister; B Rzany; P Schneede; A Schneider; S Smola; N Winter-Koch; P Wutzler; G Gross
Journal:  Vaccine       Date:  2009-04-17       Impact factor: 3.641

Review 9.  Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.

Authors:  Susanne Hartwig; Stina Syrjänen; Géraldine Dominiak-Felden; Maria Brotons; Xavier Castellsagué
Journal:  BMC Cancer       Date:  2012-01-20       Impact factor: 4.430

Review 10.  HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues.

Authors:  Margaret A Stanley; David M Winder; Jane C Sterling; Peter K C Goon
Journal:  BMC Cancer       Date:  2012-09-08       Impact factor: 4.430

View more
  5 in total

1.  [Proven and new methods in the treatment of genital warts].

Authors:  P Schneede; R Waidelich
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

Review 2.  [Human papillomavirus disease burden in men : HPV prevention is a man's business].

Authors:  P Schneede
Journal:  Urologe A       Date:  2018-12       Impact factor: 0.639

Review 3.  [Anogenital warts and HPV-associated precancers : Looking into the recently passed German S2k guideline].

Authors:  P Schneede; B Schlenker
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

Review 4.  [One decade of HPV vaccination in Germany].

Authors:  P Schneede
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

Review 5.  [Human papillomavirus and penile cancer : Thinking about measures for prevention].

Authors:  P Schneede; B Schlenker
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.